article thumbnail

What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers

FDA Law Blog

With this technology only relatively recently making its way into the clinic in a meaningful way, several other issues have been raised that warrant discussion with those who will participate in these studies and, ultimately, bear the benefits and risks of any licensed gene therapy: Genetic testing and counseling (access to newborn screening, simplified (..)

article thumbnail

Fighting viruses is as easy as breathing

The Pharma Data

Based on these studies, one of those drugs was licensed to Cantex Pharmaceuticals for the treatment of COVID-19 and other inflammatory lung diseases. They also identified several drugs that reduced the production of inflammatory cytokines in infected Alveolus Chips, which could be useful in treating excessive inflammation in the lung.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Solving the Global Clinical Trial Gap: The Case for Partnering with Multisite Lab Services

XTalks

Integrated technologies, such as the Research Use Only platform, DEPArray™*, allow for the further exploration of precision medicine by allowing researchers to easily identify and isolate single cells for downstream genetic analysis.

article thumbnail

Blood Donor Day 2023: Experts weigh in 

Drug Discovery World

NHSBT manufactures a range of advanced cell and gene therapies from a number of laboratories across England under license from the MHRA, and works with experts in hospitals, universities and commercial organisations to develop the next generation of healthcare treatments.